X
With globally dispersed supply chains, high dependence on limited API suppliers, and thin margins for generics, the life sciences industry is feeling the pressure.
Tariffs will hurt, unless companies anticipate and adapt quickly.
This new GEP bulletin outlines immediate actions and strategic steps that will help companies maintain supply continuity and stay competitive as trade barriers tighten.
What’s Inside:
- Four major risks tariffs pose to pharma and medtech
- Rapid-response tactics to manage costs and shortages
- Long-term shifts to build a more resilient supply chain
This bulletin is a must-read for procurement and supply chain leaders who want to be prepared to absorb tariff shocks and keep operations steady.